Fenofibrate and Ditropan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Ditropan (oxybutynin chloride). Common drug interactions include full blood count decreased among females and iiird nerve paralysis among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Ditropan. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

69 people who take Fenofibrate and Ditropan together, and have interactions are studied.

Fenofibrate and Ditropan drug interactions.

What are the common drug interactions of Fenofibrate and Ditropan, by gender? *:

female:

Full blood count decreased
Gait disturbance
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hyperlipidaemia (presence of excess lipids in the blood)
Inappropriate antidiuretic hormone secretion
Menopause (end of monthly cycles in women)
Muscle tightness
Muscular weakness (muscle weakness)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Pyrexia (fever)

male:

Iiird nerve paralysis (totally closed eyelid and a down and out deviation of the eye)
Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Acute respiratory failure
Anaemia (lack of blood)
Bladder cancer stage iii
Blood glucose decreased
Blood glucose increased

What are the common drug interactions of Fenofibrate and Ditropan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Adverse drug reaction
Asthenia (weakness)
Back pain
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Burning sensation
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cough
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

50-59:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Tardive dyskinesia (a disorder that involves involuntary movements)
Attention deficit/hyperactivity disorder
Dyskinesia (abnormality or impairment of voluntary movement)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Obesity (having too much body fat)
Tremor (trembling or shaking movements in one or more parts of your body)
Arthralgia (joint pain)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

Asthenia (weakness)
Dysphonia (speech disorder attributable to a disorder of phonation)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Creatinine renal clearance decreased
Dizziness
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Injection site calcification
Injection site inflammation
Injection site pain
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 14.49%
Pain: 9 people, 13.04%
Neuropathy Peripheral (surface nerve damage): 6 people, 8.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.70%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 7.25%
Type 2 Diabetes: 5 people, 7.25%
Depression: 5 people, 7.25%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 5.80%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 5.80%
Diabetes: 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Ditropan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously